Novartis CEO Vas Narasimhan signs off on a $231M deal to try something new in the R&D fight against SARS-CoV-2
Patrick Amstutz was baptized by pandemic fire early on.
He and colleagues attended the notorious Cowen conference in early March that included some of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
